Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant properties
- 1 March 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 120 (7) , 1199-1206
- https://doi.org/10.1038/sj.bjp.0701007
Abstract
1. 15-Lipoxygenase (15-LO) has been implicated in the pathogenesis of atherosclerosis because of its localization in lesions and the many biological activities exhibited by its products. To provide further evidence for a role of 15-LO, the effects of PD 146176 on the development of atherosclerosis in cholesterol-fed rabbits were assessed. This novel drug is a specific inhibitor of the enzyme in vitro and lacks significant non specific antioxidant properties. 2. PD 146176 inhibited rabbit reticulocyte 15-LO through a mixed noncompetitive mode with a Ki of 197 nM. The drug had minimal effects on either copper or 2,2'-azobis(2-amidinopropane)hydrochloride (ABAP) induced oxidation of LDL except at concentrations 2 orders higher than the Ki. 3. Control New Zealand rabbits were fed a high-fat diet containing 0.25% wt./wt. cholesterol; treated animals received inhibitor in this diet (175 mg kg-1, b.i.d.). Plasma concentrations of inhibitor were similar to the estimated Ki (197 nM). During the 12 week study, there were no significant differences in weight gain haematocrit, plasma total cholesterol concentrations, or distribution of lipoprotein cholesterol. 4. The drug plasma concentrations achieved in vivo did not inhibit low-density lipoprotein (LDL) oxidation in vitro. Furthermore, LDL isolated from PD 146176-treated animals was as susceptible as that from controls to oxidation ex vivo by either copper or ABAP. 5. PD 146176 was very effective in suppressing atherogenesis, especially in the aortic arch where lesion coverage diminished from 15 +/- 4 to 0% (P < 0.02); esterified cholesterol content was reduced from 2.1 +/- 0.7 to 0 micrograms mg-1 (P < 0.02) in this region. Immunostainable lipid-laden macrophages present in aortic intima of control animals were totally absent in the drug-treated group. 6. Results of these studies are consistent with a role for 15-LO in atherogenesis.Keywords
This publication has 53 references indexed in Scilit:
- Oxidation of Low Density Lipoproteins Greatly Enhances Their Association with Lipoprotein Lipase Anchored to Endothelial Cell MatrixPublished by Elsevier ,1996
- Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studiesCardiovascular Research, 1995
- A possible role for 15-lipoxygenase in atherogenesisTrends in Cardiovascular Medicine, 1995
- Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994
- Indications for the presence of circulating peroxidized low density lipoproteins in WHHL rabbits treated with antioxidantsAtherosclerosis, 1993
- Oxygenation of lipoproteins by mammalian lipoxygenasesEuropean Journal of Biochemistry, 1993
- Selective conversion and esterification of monohydroxyeicosatetraenoic acids by human vascular smooth muscle cells: Relevance to smooth muscle cell proliferationExperimental Cell Research, 1991
- Purification and crystallization of 15-lipoxygenase from rabbit reticulocytesBiochemical and Biophysical Research Communications, 1990
- Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988